A medication called oxybutynin designed to target overactive bladder could soon become available over the counter. This will be confirmed based on the results of a Medicines and Healthcare products Regulatory Agency (MHRA) consultation.
Overactive bladder, also known as OAB, describes a condition in which you feel a frequent and sudden urge to pee, the Mayo Clinic explains.
OAB targets millions of women in the UK that could potentially benefit from the introduction of oxybutynin without a prescription.
The MHRA’s consultation is set to determine whether Aquiette 2.5mg tablets (oxybutynin hydrochloride) should be reclassified from a prescription-only medicine (POM) to a pharmacy (P) medicine.
Speaking on ITV’s This Morning, Dr Ellie said: “This is really good news.
READ MORE: Long Covid: Four symptoms women more likely to experience, according to study
“The fact they can’t control their urine – it’s so shameful, so embarrassing, it really shouldn’t be.
“And it affects a lot of people, so being able to buy this medication, which is called oxybutynin, over the counter could really be transformative for a lot of people.
“Actually, the MHRA, who control medications in this country, want to hear from women.
“So, if anybody’s watching and they want to take this medication or they do take it on prescription, please fill out the review that you are able to online, because it could help,” the TV doctor urged.
DON’T MISS
For all the latest Health News Click Here
For the latest news and updates, follow us on Google News.
